Related Experiment Video
Updated: Jul 11, 2026
10:28
Assessment of Cocaine-induced Behavioral Sensitization and Conditioned Place Preference in Mice
Published on: February 18, 2016
18.0K
Recurrent Priapism Associated With Occupational Cocaine Exposure in a Patient With Sickle Cell Trait: A Case Report
Joel Powell1, Hallie B Thompson1, Steven J Laxton1
1Emergency Medicine, University of Tennessee Health Science Center Nashville - Saint Thomas Health, Murfreesboro, USA.
Cureus
|February 16, 2026
Summary
Occupational cocaine exposure can cause recurrent ischemic priapism, a condition previously undescribed. Healthcare providers should consider environmental and occupational sources of cocaine in patients with unexplained priapism.
Area of Science:
- Urology
- Toxicology
- Emergency Medicine
Background:
- Cocaine is a known cause of ischemic priapism due to its vasoactive properties.
- Previous case reports detail priapism from various intentional cocaine exposures.
- Recurrent priapism from occupational cocaine powder exposure has not been previously documented.
Related Concept Videos
01:21Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...